Optimizacija iskalnikov Treble razvoj kawasaki disease guidelines 2017 grm Zdrava Osnovna teorija
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Kawasaki Disease
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children
PDF] Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease | Semantic Scholar
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison | AAFP
Frontiers | Kawasaki Disease
Klimaanlage Guggenheim Museum Echo kawasaki disease complications Kindergarten Pedicab Autobiographie
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
The 2017 American Heart Association (AHA) criteria for Diagnosis of... | Download Scientific Diagram
Kawasaki disease: AHA statement and recommendations
Diagnosis and Management of Kawasaki Disease
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Kawasaki disease: AHA statement and recommendations
A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand | PLOS ONE
Links To And Excerpts From The AHA 2017 Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association - Tom Wade MD
Treatment Options for Refractory Kawasaki Disease
2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease | SpringerLink